Navitas Life Sciences

Inhalation Studies

Respiratory diseases like Asthma and Chronic Obstructive Pulmonary Disease (COPD) according to the Unmet Global Burden of COPD 2018 Report, COPD affects over 338 million people worldwide, and it is currently the third leading cause of death. In 15 years, it is expected to become the leading cause of death. Additionally as per the 2018 Global Asthma Report, every day, approximately a thousand people die of Asthma. In both cases, treatment and management using inhalation drugs are essential to ensure a healthy life for patients. 

Navitas Life Sciences enables you to bring your inhalation drug to the market quickly and effectively, ensuring better outcomes for these patients.

 

Please complete form to download PDF
First Name
Last Name
Business Email
Company
Job Title
Country
By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy | EU-US & Swiss-US Privacy Shield Policy

© 2019 Navitas Life Sciences | A TAKE Solutions Enterprise  
Privacy Policy | EU-US & Swiss-US Privacy Shield Policy